Low Dose IL-2 for the Treatment of Crohn's Disease
NCT04263831
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Crohn Disease
Interventions
DRUG:
Interleukin-2 (aldesleukin).
Sponsor
Boston Children's Hospital
Collaborators
[object Object]
[object Object]